Trial Outcomes & Findings for Hummingbird TTS Ear Tube Delivery Study (NCT NCT02165384)

NCT ID: NCT02165384

Last Updated: 2019-01-03

Results Overview

Success will be determined at the end of each ear tube procedure, by whether or not the TTS was used during the tympanostomy procedure to make an incision in the tympanic membrane and deploy an ear tube. Data may be presented when enrollment has been completed and all pre-operative and procedure data are analyzed.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

199 participants

Primary outcome timeframe

intra operative

Results posted on

2019-01-03

Participant Flow

Participant milestones

Participant milestones
Measure
Hummingbird TTS
Treatment only surgical instrument study
Overall Study
STARTED
199
Overall Study
COMPLETED
199
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Hummingbird TTS Ear Tube Delivery Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Hummingbird TTS
n=199 Participants
Treatment only surgical instrument study
Age, Customized
20 months
n=93 Participants
Sex: Female, Male
Female
NA Participants
n=93 Participants
Sex: Female, Male
Male
NA Participants
n=93 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=93 Participants
Race (NIH/OMB)
White
0 Participants
n=93 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
Race (NIH/OMB)
Unknown or Not Reported
199 Participants
n=93 Participants
Region of Enrollment
United States
199 participants
n=93 Participants

PRIMARY outcome

Timeframe: intra operative

Population: 393 ears in 199 patients received ear tube placement from the Hummingbird device.

Success will be determined at the end of each ear tube procedure, by whether or not the TTS was used during the tympanostomy procedure to make an incision in the tympanic membrane and deploy an ear tube. Data may be presented when enrollment has been completed and all pre-operative and procedure data are analyzed.

Outcome measures

Outcome measures
Measure
Hummingbird TTS
n=393 Ears
Treatment only HTTS was used to make incision and deliver ear tube
Percentage of Ears in Which an Ear Tube Was Successfully Delivered Across the Tympanic Membrane
393 Ears

PRIMARY outcome

Timeframe: Intra-operative

Any intra-operative adverse events, anticipated or unanticipated

Outcome measures

Outcome measures
Measure
Hummingbird TTS
n=199 Participants
Treatment only HTTS was used to make incision and deliver ear tube
Number of Participants With Intra-operative Adverse Events
0 Participants

Adverse Events

Hummingbird TTS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

CEO

Preceptis Medical

Phone: 6123274795

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place